These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 308095)

  • 1. Effect of the administration of L-5-hydroxytryptophan and a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    J Neurochem; 1978 Sep; 31(3):613-20. PubMed ID: 308095
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridoxal 5'-phosphate levels in brain after treatments which impair cerebral glucose metabolism.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Dec; 4(6):821-6. PubMed ID: 44547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective in vivo inhibition of monoamine oxidase in rat tissues by N-[2-(O-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW; Hemrick SK
    Proc Soc Exp Biol Med; 1978 Jul; 158(3):323-5. PubMed ID: 684000
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of dihydroxyphenylalanine administered with a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Tyce GM
    Biochem Pharmacol; 1971 Sep; 20(9):2371-84. PubMed ID: 5163149
    [No Abstract]   [Full Text] [Related]  

  • 5. N-cyclopropyltryptamines, potent monoamine oxidase inhibitors.
    Winn M; Horrom BW; Rasmussen RR; Chappell EB; Plotnikoff NP
    J Med Chem; 1975 Apr; 18(4):437-8. PubMed ID: 1079054
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamine.
    Fuller RW; Hemrick SK; Mills J
    Biochem Pharmacol; 1978; 27(18):2255-61. PubMed ID: 728176
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of monoamine oxidation in subfractions of crude mitochondria of rat brain by clorgyline and Lilly 51641.
    Mitra C; Guha SR
    Biochem Pharmacol; 1978; 27(20):2455-7. PubMed ID: 728196
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of administration of 5-hydroxytryptophan and an inhibitor of L-aromatic amino acid decarboxylase on glucose metabolism in rat brain.
    Wong KL; Tyce GM
    Neurochem Res; 1979 Apr; 4(2):277-87. PubMed ID: 313531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hepatic tyrosine aminotransferase by indole amines.
    Deguchi T; Barchas J
    J Biol Chem; 1971 Dec; 246(23):7217-22. PubMed ID: 4399704
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoamine oxidase inhibition: possible mechanism for cyproheptadine-induced alterations in insulin secretion.
    Feldman JM; Chapman BA; Plonk JW
    Life Sci; 1974 Sep; 15(6):1121-34. PubMed ID: 4157278
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of N-cyclopropyl-4-chloroamphetamine on brain serotonin metabolism in rats.
    Fuller RW; Molloy BB
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):407-18. PubMed ID: 4750092
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):207-21. PubMed ID: 7244360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic studies on rat brain monoamine oxidase.
    Huszti Z
    Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of inhibitors of 5-hydroxytryptamine uptake on plasma glucose and their interaction with 5-hydroxytryptophan in producing hypoglycaemia in mice.
    Wilson GA; Furman BL
    Eur J Pharmacol; 1982 Mar; 78(3):263-70. PubMed ID: 7040087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin depression of local cerebral glucose utilisation after monoamine oxidase inhibition.
    Grome JJ; Harper AM
    J Cereb Blood Flow Metab; 1985 Sep; 5(3):473-5. PubMed ID: 4030926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral metabolism of glucose in adrenalectomized rats: effect of treatment with L-DOPA and a monoamine oxidase inhibitor.
    Tyce GM; Owen CA
    Brain Res; 1978 Dec; 158(2):466-9. PubMed ID: 709377
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 4H-3-methylcarboxamide-1,3-benzoxazine-2-one (FI 6654) on monoaminoxidase and cerebral 5-HT.
    Suchowsky GK; Pegrassi L; Moretti A; Bonsignori A
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):332-40. PubMed ID: 5308944
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of increased brain 5-hydroxytryptamine upon the respiratory activity of cats.
    Armijo JA; Flórez J
    Neuropharmacology; 1974 Nov; 13(10-11):977-86. PubMed ID: 4548170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.